Benitec Biopharma Inc. (BNTC) Stock Forecast & Price Target
Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Benitec Biopharma Inc. (BNTC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Benitec Biopharma Inc., analysts forecast revenue rising from $25.43M in 2026 to $221.79M in 2031; the average estimate for 2031 earnings per share is $0.90; 6 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Benitec Biopharma Inc. (BNTC) forecast — frequently asked questions
What is the analyst price target for Benitec Biopharma Inc.?
Analysts covering Benitec Biopharma Inc. (BNTC) have a consensus price target of $17.00, 105.6% above the current price of $8.27. Published targets range from $14.00 to $20.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Benitec Biopharma Inc.'s earnings?
The average analyst estimate for Benitec Biopharma Inc. (BNTC) earnings per share in 2031 is 0.90, with individual estimates between 0.90 and 0.90.
How much revenue is Benitec Biopharma Inc. expected to make?
Analysts forecast Benitec Biopharma Inc. (BNTC) revenue of $221.79M in 2031, based on 2 published estimates.
How many analysts cover BNTC?
6 analysts contribute estimates for Benitec Biopharma Inc. (BNTC). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.